Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kim Lawson. (2008) Treatment options and patient perspectives in the management of fibromyalgia: future trends. Neuropsychiatric Disease and Treatment 4:6, pages 1059-1071.
Read now
Read now
Sarah M. R. Wille, Sarah G. Cooreman, Hugo M. Neels & Willy E. E. Lambert. (2008) Relevant Issues in the Monitoring and the Toxicology of Antidepressants. Critical Reviews in Clinical Laboratory Sciences 45:1, pages 25-89.
Read now
Read now
Samuel DeMaria, Afton L. Hassett & Leonard H. Sigal. (2007) N-Methyl-D-Aspartate Receptor-Mediated Chronic Pain: New Approaches to Fibromyalgia Syndrome Etiology and Therapy. Journal of Musculoskeletal Pain 15:2, pages 33-44.
Read now
Read now
Kenneth R. Kaufman & Paul J. Goodnick. (2006) Depression, Chronic Fatigue Syndrome, and Fibromyalgia. Journal Of Chronic Fatigue Syndrome 13:4, pages 77-107.
Read now
Read now
Hülya Gültekin & Murat Büyükşekerci. (2005) Magnesium increases the antinociceptive effect of amitriptyline. The Pain Clinic 17:2, pages 153-156.
Read now
Read now
Articles from other publishers (22)
Nasser M. Alorfi. (2022) Pharmacological treatments of fibromyalgia in adults; overview of phase IV clinical trials. Frontiers in Pharmacology 13.
Crossref
Crossref
Matteo Borgini, Pravat Mondal, Ruiting Liu & Peter Wipf. (2021) Chemical modulation of Kv7 potassium channels. RSC Medicinal Chemistry 12:4, pages 483-537.
Crossref
Crossref
Kinga Sałat & Anna Furgała-Wojas. (2021) Serotonergic Neurotransmission System Modulator, Vortioxetine, and Dopaminergic D2/D3 Receptor Agonist, Ropinirole, Attenuate Fibromyalgia-Like Symptoms in Mice. Molecules 26:8, pages 2398.
Crossref
Crossref
Zhuo-Ying Tao, Pei-Xing Wang, Si-Qi Wei, Richard J. Traub, Jin-Feng Li & Dong-Yuan Cao. (2019) The Role of Descending Pain Modulation in Chronic Primary Pain: Potential Application of Drugs Targeting Serotonergic System. Neural Plasticity 2019, pages 1-16.
Crossref
Crossref
Zaher A. Radi, Zachary S. Stewart, Felicity A. Grzemski & Walter F. Bobrowski. (2012) Renal Pathophysiologic Role of Cortical Tubular Inclusion Bodies. Toxicologic Pathology 41:1, pages 32-37.
Crossref
Crossref
Laura M. Traynor, Christopher N. Thiessen & Andrew P. Traynor. (2011) Pharmacotherapy of fibromyalgia. American Journal of Health-System Pharmacy 68:14, pages 1307-1319.
Crossref
Crossref
Roberto Vlainich, Adriana M. Issy, Luis R. Gerola & Rioko K. Sakata. (2010) Effect of Intravenous Lidocaine on Manifestations of Fibromyalgia. Pain Practice 10:4, pages 301-305.
Crossref
Crossref
Lesley M. Arnold. (2010) The Pathophysiology, Diagnosis and Treatment of Fibromyalgia. Psychiatric Clinics of North America 33:2, pages 375-408.
Crossref
Crossref
Raphael J Leo. (2009) Milnacipran, a serotonin and norepinephrine reuptake inhibitor: a novel treatment for fibromyalgia. International Journal of Clinical Rheumatology 4:5, pages 507-517.
Crossref
Crossref
Tomohiro Sato, Yo Matsuo, Teruki Honma & Shigeyuki Yokoyama. (2008)
In Silico
Functional Profiling of Small Molecules and Its Applications
. Journal of Medicinal Chemistry 51:24, pages 7705-7716.
Crossref
Crossref
Sami R. Achem. (2008) Treatment of Non-Cardiac Chest Pain. Disease-a-Month 54:9, pages 642-670.
Crossref
Crossref
Kim Lawson. (2008) Pharmacological treatments of fibromyalgia: Do complex conditions need complex therapies?. Drug Discovery Today 13:7-8, pages 333-340.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Lesley M. Arnold. (2007) Duloxetine and Other Antidepressants in the Treatment of Patients with Fibromyalgia. Pain Medicine 8:suppl 2, pages S63-S74.
Crossref
Crossref
Zhong-Qiu Zhao, Santina Chiechio, Yan-Gang Sun, Kai-Hua Zhang, Cheng-Shui Zhao, Michael Scott, Randy L. Johnson, Evan S. Deneris, Kenneth J. Renner, Robert W. GereauIVIV & Zhou-Feng Chen. (2007) Mice Lacking Central Serotonergic Neurons Show Enhanced Inflammatory Pain and an Impaired Analgesic Response to Antidepressant Drugs. The Journal of Neuroscience 27:22, pages 6045-6053.
Crossref
Crossref
Chris Dickens & Graham Ash. 2009. Handbook of Liaison Psychiatry. Handbook of Liaison Psychiatry
527
546
.
David L. Katz, Lindsey Greene, Ather Ali & Zubaida Faridi. (2007) The pain of fibromyalgia syndrome is due to muscle hypoperfusion induced by regional vasomotor dysregulation. Medical Hypotheses 69:3, pages 517-525.
Crossref
Crossref
Serge Perrot. (2006) Rationalizing the use of antidepressants in painful rheumatic conditions. Future Rheumatology 1:4, pages 387-391.
Crossref
Crossref
Serge Perrot, Emmanuel Maheu, Rose-Marie Javier, Alain Eschalier, Anne Coutaux, Manuela LeBars, Philippe Bertin, Bernard Bannwarth & Richard Trèves. (2006) Guidelines for the use of antidepressants in painful rheumatic conditions. European Journal of Pain 10:3, pages 185-185.
Crossref
Crossref
Deborah Antai-Otong. (2005) The Art of Prescribing. Depression and Fibromyalgia Syndrome (FMS): Pharmacologic Considerations. Perspectives In Psychiatric Care 41:3, pages 146-148.
Crossref
Crossref
Martti J Huuhka, Maija L Haanpää & Esa V.J Leinonen. (2004) Electroconvulsive therapy in patients with depression and fibromyalgia. European Journal of Pain 8:4, pages 371-376.
Crossref
Crossref
For-Wey Lung, Yi-Lin Huang, Bih-Ching Shu & Fei-Yin Lee. (2004) Parental rearing style, premorbid personality, mental health, and quality of life in chronic regional pain: A causal analysis. Comprehensive Psychiatry 45:3, pages 206-212.
Crossref
Crossref